an oral melanotic macule on lower lip Mucosal melanocytic macules Any information on dark spots – Oral melanotic macule - Stock

GHK-Cu (copper peptide) side effects reported in available literature include localized injection site reactions, mild systemic inflammation markers, and rare allergic responses

Small molecules can engage different administration routes than peptides typically use

Based on the phase 2 and phase 3 trial protocols: Weeks 1-4: 1 mg once weekly Weeks 5-8: 2 mg once weekly Weeks 9-12: 4 mg once weekly Weeks 13-16: 8 mg once weekly Weeks 17 onward: 12 mg once weekly (maximum dose) The starting dose of retatrutide is deliberately low because the triple-agonist mechanism produces more intense initial side effects than single-pathway compounds

The largest study to assess the outcomes in the offspring of patients with ICP